Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's Locations section was updated to include a consolidated list of states. Individual state location pages were removed, and the revision updated to v3.3.3.SummaryDifference0.8%

- Check53 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed, reflecting a page version metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoved the government funding lapse notice; the study details content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedNo meaningful content changes detected between the two screenshots; no additions or deletions affecting core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check103 days agoChange Detected- Added a government funding/operating status notice and a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the resource: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (v3.1.0).SummaryDifference2%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.